Cuba invests $240M in pharma expansion

15 December 2008

Cuba is to invest over 190.0 million euros ($240.0 million) to expand its pharmaceutical industry in the period to 2010. The program includes the construction of modern plants to manufacture injectables, aerosols and medicinal compounds.

Older units will be revamped with the aim, the authorities say, of making drugs "more efficacious" and to achieve a higher level of stability for the sector. The drug industry was badly affected by the economic crisis after the break-up of the Soviet bloc.

Currently, Cuba imports drugs worth over $100.0 million annually though it also produces 95% of national consumption, according to Farmacuba director Roberto Dominguez, and exports generic drugs and blood products worth $220.0 million (+22% on 2008) to over 50 countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight